|
Latest Posts By WL123456
- Supreme
|
|
| 08-Jun-2021 13:35 |
Sunpower
/
Re-look at Sunpower
|
||||
|
|
Just a gentle reminder that today will be the last day to be in for three tranche of dividends
Two tranche totalling $0.289 and one tranche of $0.003. Total dividend is $0.2893. Ex dividend, company will be focusing on green tech business where its has secured long term stable revenue generating contracts. Management is also expecting more contracts from local municipals in line with the CCP push towards a greener China. |
||||
| Good Post Bad Post | |||||
| 04-Jun-2021 14:27 |
Kim Heng
/
M&A TARGET STRONG BALANCE SHEET 2018 GAME CHANGER
|
||||
|
|
Projects on supplying windfarm with services is bearing fruit while OSVs contracts terms are getting better. NAV of $0.078 makes current price compelling and chairman has and wife has been busy scooping up shares from $0.03. Other than windfarm, there?s also other diversification that is promising. Company management is at least trying to move according to global trends.
|
||||
| Good Post Bad Post | |||||
| 04-Jun-2021 14:22 |
Sunpower
/
Re-look at Sunpower
|
||||
|
|
First tranche of dividend is $0.1406 cut off date on 9/6/21. Second tranche of dividend date yet to be determine but should be around august. All proceeds has been received by Sunpower and is in an offshore escrow account. | ||||
| Good Post Bad Post | |||||
| 04-Jun-2021 11:15 |
RH PetroGas
/
What happen to RH PetroGas
|
||||
|
|
Next to watch is Kim Heng. RH has a nav of negative 0.024 (-0.024) while Kim Heng has a nav of $0.078. Definitely a lot more room for Kim Heng.
|
||||
| Good Post Bad Post | |||||
| 17-Feb-2021 11:25 |
AEM SGD
/
business turnaround ?
|
||||
|
|
Now based TA, the stock price is retracing but long term wise will be good. I like the future plans of the company but the company will likely do a stock split to bring down the price for more equitable trades in terms of volume and frequency. Good to accumulate on dips and weakness of the market.
|
||||
| Good Post Bad Post | |||||
| 24-Aug-2020 02:07 |
Vicplas Intl
/
Vicplas: Inspiring Medical Bull at the Forefront
|
||||
|
|
Apparently, you didn?t read the circular by MAS. MAS has given sgx regco the power to refer companies to CAD for investigation if there is frequent query by sgx regco. In their latest query, sgx regco clearly warn vicplas this is the second query in a month. Under the MAS trade surveillance practice guide, it clearly approved the sgx regco the power to suspend any company pending investigation that sgx regco warranted. I didn?t not spread rumour. I merely state what MAs and regco will do if there is a increase in frequency of query. Furthermore I used the words ?may? and never say mist happen. By quoting MAS , circular ( page 20-21), I fear monger? So MAS also fear monger all the sgx listed company? If the company does Norbert have frequent query, they sit need to be afraid. Anyway the suspension will morning affect vicplas company itself. It is to investigate the trading accounts behind vicplas shares. Vicplas will continues business as usual. Once investigations are over, vicplas can continue to trade normally. So there?s is no fear for vicplas shareholders as it?s not due to company financial irregularities. It?s to investigate the Traders behind vicplas.
|
||||
| Good Post Bad Post | |||||
| 24-Aug-2020 01:47 |
Vicplas Intl
/
Vicplas: Inspiring Medical Bull at the Forefront
|
||||
|
|
I don?t have to answer you. The answer is already with sgx second query in a month and vicplas company?s rely to sgx regco. MAS introduce new rules last year that companies that is repeatedly warn about their trading frequencies will be investigated. It?s not the company that will be investigated. It?s the trading accounts behind the manipulation. Kitchen culture is a good example as SGX will refer the accounts to CAD. For more info, please read up MAS circular on Trade surveillance practice guide issued 08/2019. As for medtecs, I merely state it?s survive the sell off. I never even state it?s TP. Some has a TP of $3 and some even $8. Why don?t u ask them lol. I merely quoted TA wise, demand for The stock is still there. Beside, sgx has quried medtecs and they are satisfied with their response. Do you see sgx regco deliverer a second query within a month?
|
||||
| Good Post Bad Post | |||||
| 24-Aug-2020 01:27 |
Sembcorp Ind
/
SembCorp Industries
|
||||
|
|
I am not vested but I believe the FA will be better without SCM. If the price drop further, I believe it?s a good buy between $1.73-$1.77. Morale of SCI management will also be higher since they are cleared on a massive problems for years to come.
|
||||
| Good Post Bad Post | |||||
| 24-Aug-2020 01:11 |
Sembcorp Ind
/
SembCorp Industries
|
||||
|
|
Manage to cut off the tumour is a good first step. Be patient and SCI will be back. Utilities and other defensive segments will continue to see it grow. But it won?t be fast. Soon the effect of cutting off the tumour will be forgotten and with a better set of results post SCM, one will see better days ahead of the share price. | ||||
| Good Post Bad Post | |||||
| 24-Aug-2020 01:01 |
Vicplas Intl
/
Vicplas: Inspiring Medical Bull at the Forefront
|
||||
|
|
Don?t worry, the durian company already warn me they don?t know why their durian so expensive so I am an obedient customer. I won?t buy if the boss himself tells me he also don?t know why his durian so expensive. I won?t buy anything that?s overvalued. But I can?t say that for others. While I like reasonable priced durians, others may like expensive ones. To each his taste. But I am just hoping to find like minded investors. If you find my post disgusting or offensive, I apologise and you can kindly skip. Thanks.
|
||||
| Good Post Bad Post | |||||
| 24-Aug-2020 00:35 |
Vicplas Intl
/
Vicplas: Inspiring Medical Bull at the Forefront
|
||||
|
|
If this will impact their share price, I am sure vicplas will mention in their reply to sgx regco that dpm has visited one of their subsidiary and this has caused vicplas to increase their revenue by 1000% and improve cash flow by $50m. Maybe you send an email to MAS to help vicplas explain. Again, not for vicplas fans and supporters. Just offering an alternative view for would be buyers to consider. You can chase but remember to take profit before it ends. But if vicplas announces something positive that results in their roaring share price, by all means put your money in. :s
|
||||
| Good Post Bad Post | |||||
| 24-Aug-2020 00:30 |
Vicplas Intl
/
Vicplas: Inspiring Medical Bull at the Forefront
|
||||
|
|
Isn?t it obvious that it?s an announcement from the business times? How is that misleading? I quoted business times. And one should always refer to business times for the full report. You should agree that everyone should dyodd right? So must read up mah. Ok I make you happy :D. After the worse Sept 29, al words are mine :D and I already state for vicplas fans and supporters, please ignore and and continue to support the price up.
|
||||
| Good Post Bad Post | |||||
| 24-Aug-2020 00:26 |
Vicplas Intl
/
Vicplas: Inspiring Medical Bull at the Forefront
|
||||
|
|
For those who wants to know what?s powers sgx regco have, visit this link and look under frequency of trading under undue influence. If the frequency is up, MAS will take note of those brokers account and investigate. Be warning is to take note and twice within a month means MAS is watching. So i would advice buyers to take any profit if possible. Not suggesting not to buy but don?t get drag down once the volume die down. Again, not for vicplas fans and supporters. I am just offering an alternative view. Don?t take me seriously. :D | ||||
| Good Post Bad Post | |||||
| 24-Aug-2020 00:10 |
Vicplas Intl
/
Vicplas: Inspiring Medical Bull at the Forefront
|
||||
|
|
For those neutral and intending to enter, not for those bullish and very keen on vicplas,
SINGAPORE (THE BUSINESS TIMES) - Pipe-maker VicPlas International has said that the company is not aware of any information concerning it or its units that has not been announced which might explain the spike in its share price last Friday (Aug 21). Also, the mainboard-listed company in the statement on Saturday to Singapore Exchange (SGX) said that it does not have any explanation for the unusual price movements, which had triggered the bourse operator's queries on Friday. Shares in VicPlas closed at 59 Singapore cents on Friday, up nearly 47.5 per cent from the day before. Some 126.9 million shares changed hands. This is the second time this month that VicPlas, which manufactures and distributes pipes, has been queried by SGX for trading activity. The last query was on Aug 3, to which it had responded at the time that it had given similar replies. The company's financial results for the financial year ended July 30 will be released by Sept 29. If you have been following sgx regco announcement, usually when they announce second warning to the Traders behind vicplas, their patient Is running thin. They may suspend vicplas and call for an investigation into share rigging like Blumont and Asiasons (John Soh and gang), or issue a Trade with caution(TWC) and get CAD to investigate the accounts. If you intend to buy, take whatever profit you have if can get and move on. This company ain?t medtec and won?t have earnings to support their value. Upcoming 29/9 you will get what I mean. vicplas fan so and supporters can ignore this post. Good luck. |
||||
| Good Post Bad Post | |||||
| 17-Aug-2020 08:28 |
Asian Healthcare
/
Asian Healthcare Specialists Limited (1J3)
|
||||
|
|
China? I think you read carefully first:
ASIAN Healthcare Specialists (AHS) said on Wednesday that it is partnering Temasek Holdings' Heliconia unit to pursue healthcare investments in South-east Asia. The two have formed a co-investment vehicle, Fansipan 2, for this purpose, with Heliconia taking a majority stake. Heliconia, through its Encyclia 1 Investments unit, will take a 76.2 per cent in Fansipan 2 for S$25.6 million. Meanwhile, AHS, through subsidiary Salvia Ventures, will subscribe for a 23.8 per cent stake for S$8 million. The total sum of S$33.6 million will serve as the first tranche of funding for any healthcare or healthcare-related investments in South-East Asia - as identified by Heliconia, after consulting with AHS. AHS said it will fund its investment in Fansipan 2 with a combination of proceeds from convertible bonds it intends to issue to Heliconia, the remainder of the net proceeds raised from its initial public offering of S$2.1 million and internal resources. The group is proposing to issue a S$3 million convertible bond to Encyclia and a S$1 million convertible bond to Vanda 1 Investments (another Heliconia unit), both with zero coupon.
|
||||
| Good Post Bad Post | |||||
| 17-Aug-2020 08:07 |
Asian Healthcare
/
Asian Healthcare Specialists Limited (1J3)
|
||||
|
|
SINGAPORE] Singapore's Temasek Holdings has become one of the largest shareholders of BlackRock Inc after it added a 3.9 per cent stake in the money manager that's worth about US$3.5 billion.
The state-owned investor was one of several players that bought BlackRock shares when PNC Financial Services Group Inc sold a US$14 billion stake this year, according to people familiar with the matter. Temasek added 5.95 million shares in the second quarter, according to its 13F filings Friday with the US Securities and Exchange Commission. The investment has already paid dividends for Temasek, with BlackRock rising 8.4 per cent since June 30, closing Thursday at US$589.56 in New York. Temasek is now the fifth-largest shareholder, according to data compiled by Bloomberg. The two companies have worked together in the past, with talks underway for a joint venture in China. The Temasek effect. With heliconia in Asian healthcare, expect share price to shoot north. With more of their plans to be revealed in the near future, expect this company to rise through among this Covid19 pandemic. AHS is proposing to issue a zero-coupon convertible bond to Vanda 1 in the aggregate principal amount of S$5 million due in2021, convertible in whole or in part into fully-paid ordinary shares in the capital of the company at a conversion price of 25 Singapore cents per conversion share, subject to adjustments in accordance to the agreement's provisions. AHS is also proposing to grant a non-listed share option, to be exercised in whole or in part, carrying the right to subscribe for such number of ordinary shares in its capital for an aggregate consideration of S$5 million at the exercise price of 32.5 Singapore cents per option share, which is subject to the adjustment events. The conversion price represents a premium of 0.2 per cent and the option price, a premium of 30.3 per cent over the volume-weighted average price of 24.95 Singapore cents for trades on the Singapore Exchange on Oct 12, the full market day immediately preceding the signing of the investment agreement. Should be worth at least 0.325. In fact a longer term target of $0.50 should be attainable once foreign funds starts joining Temasek and starts to buy into Asian healthcare :D |
||||
| Good Post Bad Post | |||||
| 12-Aug-2020 01:19 |
UG Healthcare
/
UG Healthcare Corporation
|
||||
|
|
Your return for home $337,000 worth of UG stocks NOW is $714 plus what ever price it might appreciate if it even can. Worth the deal? I offer you a better deal $2714! How ? :D
|
||||
| Good Post Bad Post | |||||
| 11-Aug-2020 15:07 |
Asian Healthcare
/
Asian Healthcare Specialists Limited (1J3)
|
||||
|
|
They are already in.
|
||||
| Good Post Bad Post | |||||
| 11-Aug-2020 09:59 |
Alset
/
Singapore-eDev
|
||||
|
|
There will be another announcement to support the first announcement that SeD made with regards to Covid19. Till then, I don?t think they want to negate the effect of the push up of prices during the first announcement. Stay tune and wait for the second announcement. | ||||
| Good Post Bad Post | |||||
| 11-Aug-2020 09:57 |
Asian Healthcare
/
Asian Healthcare Specialists Limited (1J3)
|
||||
|
|
Look long term. $.40-$0.50 possible. Once Temasek is in, due diligence done :D
|
||||
| Good Post Bad Post | |||||
| First 1-20 of 4589 Older> Last |

